The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means
This non-discretionary tax withholding reduced the CTO of Hims' direct holdings, though he retains roughly 194,000 shares and roughly 2 million derivative securities subject to multi-year vesting.
Overview
CTO Mohamed Elshenawy reported a non-discretionary sale of 95,798 shares of Hims & Hers Health, Inc. (NYSE:HIMS) at $28.15 per share on August 14, according to a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($28.15); post-transaction value based on the August 14 market close ($28.15).
Details
Hims & Hers Health operates as a leading digital health platform with a $6.4 billion market capitalization and $2.6 billion in TTM revenue, positioning itself at the intersection of telehealth and direct-to-consumer pharmaceutical distribution. The company's integrated platform model creates competitive advantages through operational efficiency, customer convenience, and data-driven personalization. Despite current net losses of $142.0 million TTM, the company's substantial revenue base and market scale reflect strong consumer adoption of its digital-first healthcare delivery model.
Source
Originally published at www.fool.com.